Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Research in Real-Life Ltd
With
Teva Branded Pharmaceutical Products R&D, Inc.
University of Sydney
Woolcock Institute of Medical Research
University of Technology, Sydney
The University of New South Wales
The purpose of this study is to identify how intuitive devices are to use and what level of training is required to ensure that HCPs are able to demonstrate the correct technique. The two devices examined will be the SYMBICORT TURBOHALER and placebo Budesonide/Formoterol SPIROMAX device among healthcare professionals (HCP).
Age
Any age
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Written informed consent is obtained and dated by the participant before conducting any study related procedures.
The participant is a student that is currently enrolled in the University where the study is conducted
The participant must be willing and able to comply with study restrictions and to remain at the study site for the required duration during the study period, and willing to return to the site for the follow up evaluation as specified in this protocol.
The participant has not previously used or received training in the use of either the SPIROMAX or the TURBOHALER in the last 6 months
You may not be if
Participants will be excluded from participating in this study if they have asthma.
